Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 66
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Eur J Pediatr ; 181(3): 1167-1174, 2022 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-34782946

RESUMEN

To evaluate the risk factors for crusted scabies in children in France. The retrospective multicenter study, conducted in France, of children (aged < 18 years) with profuse and/or crusted scabies confirmed by dermoscopy and/or microscopy. Data were obtained using a standardized questionnaire. We included 20 children. The mean age was 4.5 years, and 70% of the patients were girls. Their medical history revealed a neurological pathology (agenesis of the corpus callosum; n = 1, 5.0%), prematurity (n = 1, 5.0%), Down syndrome (n = 1, 5.0%), atopic dermatitis (n = 2, 10%), and asthma (n = 2, 10.0%). Fifteen (75.0%) children were treated with steroids before being diagnosed with scabies: 12 (60.0%) with topical steroids, one (5.0%) with a systemic steroid, and two (10.0%) with inhaled steroids. One child (5.0%) lived in a precarious environment. The mean duration of pruritus was 3.4 months, and that of the skin lesions was 3.1 months. The most commonly affected areas for crusted scabies were the palms/hands (66.7%) and the armpits (33.3%). Thirteen children (65.0%) were hospitalized, 14 (70.0%) were treated with ivermectin and all received topical treatments; 85.7% were cured within an average of 38 days, but one child had a relapse 3 months later in the form of common scabies.Conclusion: The main risk factor for developing crusted scabies in France was the misdiagnosis and the use of corticosteroids, especially topical forms typically used in "healthy" children. Management of the children was effective and similar to that used in adults. What is Known: • Crusted scabies is an extremely contagious disease which is rarely reported in infancy, especially in healthy children. • The main risk factors include immunosuppression, physical debilitation, and intellectual disability. What is New: • The main risk factor of severe scabies in this study was delayed diagnosis associated with the use of topical or systemic corticosteroids. • The treatment was successful in 85.7% of cases, and 65% of children needed to be hospitalized.


Asunto(s)
Escabiosis , Administración Tópica , Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Terapia de Inmunosupresión , Ivermectina/uso terapéutico , Estudios Retrospectivos , Escabiosis/diagnóstico , Escabiosis/tratamiento farmacológico , Escabiosis/epidemiología
2.
Australas J Dermatol ; 62(4): e563-e567, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34570367

RESUMEN

BACKGROUND: Crusted scabies results from a failure of the host immune response to control the proliferation of the scabies mite in the skin, with resulting hyperinfestation and a concomitant inflammatory and hyper-keratotic reaction. However, it has also been recognised in people with no evident immunological deficit. CASE HISTORY: We present a case report of apparently immunocompetent 16-year-old female presenting with multiple hyperkeratotic vegetating plaques over limbs, excoriated papules over trunk with minimal itching since 2 years without any positive family history. The microscopic examination of the skin scales with potassium hydroxide demonstrated numerous scabies mites and eggs. Histopathology showed hyperkeratosis with multiple mites in stratum corneum. Numerous mites were seen on biopsy of lesion. X-ray showed osteolysis of distal phalanges secondary to chronic pressure. Repeated topical treatments with permethrin and oral ivermectin led to the considerable resolution of her lesions. CONCLUSION: We present a rare case of crusted scabies with osteolysis in an immunocompetent female.


Asunto(s)
Osteólisis/diagnóstico por imagen , Osteólisis/etiología , Escabiosis/complicaciones , Escabiosis/diagnóstico , Adolescente , Antiparasitarios/uso terapéutico , Femenino , Humanos , Ivermectina/uso terapéutico , Osteólisis/terapia , Permetrina/uso terapéutico , Escabiosis/tratamiento farmacológico
3.
J Cutan Med Surg ; 25(1): 95-101, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-32998532

RESUMEN

BACKGROUND: Scabies is globally ubiquitous and is a significant health issue for institutions, the economically disenfranchised, resource-poor areas, and for those with weakened immune systems. Topicals are usually effective, but are cumbersome and expensive to use in large populations and for those nonadherent to topicals. Oral ivermectin became available in Canada for the off-label treatment of scabies in the fall 2018. OBJECTIVES: To review the diagnosis and management of scabies. Dose schedules and concomitant management measures are outlined for scabies simplex and for crusted scabies. Ivermectin use is outlined. METHODS: Medline, colleague discussions, practice review, and experience from managing scabies in institutions. RESULTS: Oral ivermectin is safe, easier to use, cheaper, more effective, and more economical than topicals in widespread institutional scabies, for those nonadherent to topicals, and in crusted scabies. CONCLUSIONS: Oral ivermectin is the treatment of choice in large populations, the nonadherent, and for crusted scabies. Oral ivermectin is produced by Merck Canada as Stromectol 3 mg. The treatment dose for noncrusted scabies is 200 µg/kg, taken in a single dose with food. For example, 15 mg (5 tablets) for a 70 kg person. Retreat in 10-14 days to enhance effectiveness, and perhaps to reduce scabicide resistance.


Asunto(s)
Antiparasitarios/uso terapéutico , Ivermectina/uso terapéutico , Escabiosis/diagnóstico , Escabiosis/tratamiento farmacológico , Administración Cutánea , Administración Oral , Antiparasitarios/administración & dosificación , Humanos , Insecticidas/uso terapéutico , Ivermectina/administración & dosificación , Permetrina/uso terapéutico , Escabiosis/prevención & control , Escabiosis/transmisión
4.
J Am Acad Dermatol ; 82(3): 533-548, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31310840

RESUMEN

Scabies is an ectoparasitic dermatosis caused by Sarcoptes scabiei var. hominis and is a public health issue in all countries regardless of socioeconomic status. In high-income countries, delays in diagnosis can lead to institutional outbreaks; in low- and middle-income countries, poor access to health care contributes to disease undertreatment and long-term systemic sequelae. With scabies now recognized as a neglected tropical disease by the World Health Organization, increased awareness and systematic efforts are addressing gaps in diagnosis and treatment that impede scabies control. This review summarizes the available data and provides an update on scabies epidemiology, clinical features, diagnosis, management, and public health considerations.


Asunto(s)
Brotes de Enfermedades/prevención & control , Insecticidas/uso terapéutico , Enfermedades Desatendidas/terapia , Sarcoptes scabiei , Escabiosis/terapia , Animales , Diagnóstico Tardío , Diagnóstico Diferencial , Evaluación de la Discapacidad , Carga Global de Enfermedades , Humanos , Enfermedades Desatendidas/diagnóstico , Enfermedades Desatendidas/epidemiología , Enfermedades Desatendidas/parasitología , Años de Vida Ajustados por Calidad de Vida , Escabiosis/diagnóstico , Escabiosis/epidemiología , Escabiosis/parasitología , Piel/diagnóstico por imagen , Piel/parasitología , Organización Mundial de la Salud
5.
Transpl Infect Dis ; 22(2): e13193, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31605666

RESUMEN

BACKGROUND: Crusted scabies (CS) is a rare, severe and highly contagious form of scabies, which has been reported in immunosuppressed patients. A high index of suspicion and awareness of CS is essential to treat this infestation. CASE: A 13-year-old boy presented with pruritic hyperkeratotic squamous plaques located on both inner wrists, the web spaces of both his hands and his feet, and the genital area of 12 months duration. He was diagnosed with focal segmental glomerulosclerosis at the age of 5 and received a kidney transplant at the age of 9. He has been on a maintenance dose of prednisone (5 mg/d) and mycophenolate mofetil (250 mg/d) for the past 2 years. He had a contact history with a school friend with similar lesions. A skin punch biopsy demonstrated the presence of multiple mites in the stratum corneum confirming the diagnosis of CS. Ivermectin, the recommended drug of choice for crusted scabies, is not available in South Africa. The patient was commenced on topical benzoyl benzoate lotion but discontinued its use because of intolerable irritation. We subsequently prescribed the daily application of topical 5% sulfur in petrolatum to which his pruritus subsided significantly after 2 weeks with resolution of all skin lesions at the end of 8 weeks. CONCLUSION: This case is the first documented report of CS in a pediatric renal transplant patient. Our management highlights that classic formularies of magistral drugs are still effective treatment options and can be used especially when standard therapies cannot be tolerated or when optimum treatments are not available.


Asunto(s)
Huésped Inmunocomprometido , Escabiosis/diagnóstico , Receptores de Trasplantes , Adolescente , Benzoatos/efectos adversos , Benzoatos/uso terapéutico , Biopsia , Humanos , Trasplante de Riñón , Masculino , Prednisona/efectos adversos , Prednisona/uso terapéutico , Prurito/diagnóstico , Prurito/etiología , Escabiosis/tratamiento farmacológico , Piel/patología , Azufre/administración & dosificación
6.
Trop Med Int Health ; 24(3): 280-293, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30582783

RESUMEN

We conducted a systematic review of the treatment, prevention and public health control of skin infections including impetigo, scabies, crusted scabies and tinea in resource-limited settings where skin infections are endemic. The aim is to inform strategies, guidelines and research to improve skin health in populations that are inequitably affected by infections of the skin and the downstream consequences of these. The systematic review is reported according to the PRISMA statement. From 1759 titles identified, 81 full text studies were reviewed and key findings outlined for impetigo, scabies, crusted scabies and tinea. Improvements in primary care and public health management of skin infections will have broad and lasting impacts on overall quality of life including reductions in morbidity and mortality from sepsis, skeletal infections, kidney and heart disease.


Nous avons effectué une analyse systématique du traitement, de la prévention et du contrôle de santé publique des infections cutanées comprenant l'impétigo, la gale, la gale en croûte et la teigne, dans des cadres à ressources limitées où les infections cutanées sont endémiques. Le but étant d'informer les stratégies, les directives et la recherche pour améliorer la santé de la peau dans les populations qui sont touchées de manière inéquitable par les infections cutanées et leurs conséquences plus tard. La revue systématique est rapportée selon la déclaration PRISMA. Sur 1759 titres recensés, 81 études en texte intégral ont été passées en revue et les principaux résultats rapportés concernant l'impétigo, la gale, la gale en croûte et la teigne. Les améliorations apportées dans la prise en charge des infections de la peau dans les soins de santé primaires et les soins de santé publique auront des répercussions vastes et durables sur la qualité de vie en général, notamment une réduction de la morbidité et de la mortalité dues au sepsis, aux infections du squelette, aux maladies du rein et du cœur.


Asunto(s)
Dermatomicosis/terapia , Impétigo/terapia , Escabiosis/terapia , Dermatomicosis/prevención & control , Humanos , Impétigo/prevención & control , Salud Pública , Escabiosis/prevención & control
7.
Transpl Infect Dis ; 21(3): e13077, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30873722

RESUMEN

Crusted scabies is a rare disease variant associated with T-cell dysregulation. Transplant patients are at risk of developing crusted scabies as a consequence of their immunosuppressive regimens. We report a case of crusted scabies presenting with recurrent septicemia in a 65-year-old renal transplant recipient, treated with daily ivermectin for 7 days after initial failure of weekly ivermectin dosing. A literature review of crusted scabies in transplant recipients consisting of 19 cases reports was summarized. Pruritus was common, and initial misdiagnosis was frequent. Most were treated with topical therapy, with one-third receiving ivermectin. Three of seven cases presenting with a concomitant infection died. Crusted scabies is commonly misdiagnosed in transplant recipients owing to its rarity, varied appearance, and different skin distributions. It should be considered in the differential diagnosis of transplant recipients presenting with rash and pruritus, given its association with secondary infection and subsequent mortality.


Asunto(s)
Ivermectina/uso terapéutico , Trasplante de Riñón/efectos adversos , Escabiosis/diagnóstico , Escabiosis/tratamiento farmacológico , Administración Oral , Anciano , Animales , Diagnóstico Diferencial , Exantema , Humanos , Terapia de Inmunosupresión/efectos adversos , Masculino , Recurrencia , Sarcoptes scabiei/efectos de los fármacos , Sepsis/tratamiento farmacológico , Piel/inmunología , Piel/patología , Vancomicina/uso terapéutico
8.
Allergol Immunopathol (Madr) ; 46(3): 276-280, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29279260

RESUMEN

Scabies is observed with relatively high frequency in Allergy and Dermatology clinics in developing countries where poor sanitary conditions are prevalent and increasingly in some areas of the world with increased immigrant populations. Since the immunological response to scabies mites includes the production of IgE class antibodies to Sarcoptes scabiei allergens which cross-react with Dermatophagoides major allergens Der p 1 and Der p 2, positive immediate-type skin tests to house dust mite extracts should be interpreted cautiously. Additionally, scabies should be included routinely in the differential diagnosis of itchy rashes in patients living in those areas.


Asunto(s)
Hipersensibilidad/diagnóstico , Escabiosis/diagnóstico , Alérgenos/inmunología , Animales , Antígenos Dermatofagoides/inmunología , Reacciones Cruzadas , Diagnóstico Diferencial , Humanos , Hipersensibilidad/inmunología , Pyroglyphidae , Sarcoptes scabiei , Escabiosis/inmunología , Escabiosis/patología
10.
Ann Dermatol Venereol ; 143(4): 275-8, 2016 Apr.
Artículo en Francés | MEDLINE | ID: mdl-26969477

RESUMEN

BACKGROUND: Crusted scabies, also known as Norwegian scabies, is a rare and extremely debilitating form of Sarcoptes scabiei var. hominis infestation that generally occurs in immunosuppressed patients. Herein, we report a "historic" and fatal case. PATIENTS AND METHODS: A 52-year-old woman was admitted to the emergency department presenting crusted dermatitis together with extreme deterioration of her general condition. Her general practitioner had initiated dermo-corticosteroid therapy for suspected atopic dermatitis two months earlier, and she had been confined to bed for the previous 10 days. Her son presented pruritus that became worse at night. On examination the patient was moaning, dehydrated and confused and her entire skin was hyperkeratotic, with very thick, yellowish, cracked crusts covering 40 % of her body. Tests indicated severe water and electrolytic disorders as well as Staphylococcus aureus bacteremia. A tape test established the diagnosis of crusted scabies. The severity was grade III on the Davis clinical grading scale. The patient showed signs of multi-organ failure and was transferred to intensive care, but she died during the night. DISCUSSION: This case is remarkable for its historic severity. In France, scabies infestation is a re-emerging disease and has been a public health priority since 2012. The rare hyperkeratotic form is not fully understood and frequently diagnosed late, in some cases with a fatal outcome.


Asunto(s)
Errores Diagnósticos , Escabiosis/diagnóstico , Diagnóstico Tardío , Dermatitis Atópica/diagnóstico , Resultado Fatal , Femenino , Humanos , Persona de Mediana Edad , Insuficiencia Multiorgánica/etiología , Escabiosis/complicaciones , Infecciones Estafilocócicas/etiología , Sobreinfección/etiología , Desequilibrio Hidroelectrolítico/etiología
11.
Ann Dermatol Venereol ; 143(4): 251-6, 2016 Apr.
Artículo en Francés | MEDLINE | ID: mdl-26948093

RESUMEN

Crusted scabies is a rare and severe form of infestation by Sarcoptes scabies var. hominis. It is characterized by profuse hyperkeratosis containing over 4000 mites per gram of skin, with treatment being long and difficult. The condition is both direct and indirectly contagious. It has a central role in epidemic cycles of scabies, the incidence of which is on the rise in economically stable countries. Recent discoveries concerning the biology of mites, the pathophysiology of hyperkeratosis and the key role of IL-17 in this severe form open up new therapeutic perspectives.


Asunto(s)
Escabiosis , Acaricidas/farmacología , Acaricidas/uso terapéutico , Animales , Diagnóstico Tardío , Humanos , Interleucina-17/fisiología , Ivermectina/farmacología , Ivermectina/uso terapéutico , Sarcoptes scabiei/efectos de los fármacos , Sarcoptes scabiei/fisiología , Escabiosis/diagnóstico , Escabiosis/tratamiento farmacológico , Escabiosis/epidemiología , Escabiosis/fisiopatología , Índice de Severidad de la Enfermedad , Sobreinfección
12.
Am J Ind Med ; 58(5): 577-82, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25777802

RESUMEN

BACKGROUND: The optimal approach to managing institutional scabies outbreaks has yet to be defined. We report on outbreak managements are needed. METHODS: We report on a large outbreak of scabies in three acute care wards in a tertiary university teaching hospital in the Netherlands. RESULTS: The outbreak potentially effected 460 patients and 185 health care workers who had been exposed to the index patient. CONCLUSION: Containment of an outbreak relies on a quick and strict implementation of appropriate infection control measures and should include simultaneous treatment of all infested persons and exposed contacts to prevent secondary spread and prolonged post-intervention surveillance.


Asunto(s)
Personal de Salud , Control de Infecciones/métodos , Transmisión de Enfermedad Infecciosa de Paciente a Profesional , Escabiosis/transmisión , Adulto , Brotes de Enfermedades , Femenino , Hospitales de Enseñanza , Humanos , Países Bajos , Escabiosis/epidemiología
13.
Paediatr Child Health ; 20(7): 395-402, 2015 Oct.
Artículo en Inglés, Francés | MEDLINE | ID: mdl-26527041

RESUMEN

Scabies is a contagious skin infestation caused by a mite. It causes significant global morbidity, with an estimated 300 million cases annually. Although it can affect individuals at any socioeconomic level, individuals who live in poverty or in overcrowded conditions are at much higher risk for scabies. Lack of local expertise can result in failure to recognize scabies, leading to delayed diagnosis and inadequate treatment of cases and contacts. Scabies disproportionately affects many Indigenous (First Nations, Inuit, Métis) communities where risk factors are present. Scabies risk is also higher in young children, the elderly and immunocompromised individuals. Institutional outbreaks of scabies have also been reported. Apart from a very itchy rash, scabies can lead to secondary bacterial infections and related complications, as well as to stigmatization, depression, insomnia and significant financial costs. Topical antiscabies lotions are still the mainstay of treatment, but oral ivermectin has also proven effective under certain circumstances. Asymptomatic and symptomatic household members should all be treated at the same time. In Canada and globally, the presence of scabies is usually a symptom of poor living conditions and a sign that basic necessities need improvement. Clinicians who work with Indigenous communities can improve their ability to diagnose and treat scabies, and should advocate for better living conditions where scabies is prevalent.


La gale est une infestation cutanée contagieuse causée par un acarien. Elle est responsable d'une morbidité importante dans le monde, puisqu'environ 300 millions de nouveaux cas se déclarent chaque année. Même si elle touche des individus de tous les milieux socioéconomiques, les personnes qui vivent dans la pauvreté ou qui habitent dans des logements surpeuplés y sont beaucoup plus vulnérables. À cause de l'absence de compétences locales, la gale risque de passer inaperçue, ce qui peut entraîner un retard de diagnostic et un traitement inadéquat des cas et des contacts. La gale est présente dans un nombre disproportionné de communautés autochtones (Premières nations, Inuits, Métis) où interviennent des facteurs de risque. Le risque de gale est également plus élevé chez les jeunes enfants, les personnes âgées et les personnes immunodéprimées. Des éclosions de gale se produisent également dans des établissements fermés. À part un prurit intense, la gale peut susciter des infections bactériennes secondaires et des complications connexes, de même que des préjugés, une dépression, de l'insomnie et des coûts financiers importants. Les lotions topiques contre la gale demeurent le pilier du traitement, mais l'ivermectine par voie orale s'est révélée efficace dans certaines situations. Les membres asymptomatiques et symptomatiques du ménage doivent tous être traités en même temps. Au Canada et dans le monde, la gale est généralement révélatrice de pauvreté et de manque d'accès aux besoins de première nécessité. Les cliniciens qui travaillent auprès des communautés autochtones peuvent améliorer leur capacité de diagnostiquer et de traiter la gale et doivent préconiser de meilleures conditions de vie dans les milieux où la gale est répandue.

14.
J Clin Microbiol ; 57(9)2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-31451570
16.
Parasite Immunol ; 36(11): 594-604, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25040151

RESUMEN

Scabies is an ectoparasitic infestation by the mite Sarcoptes scabiei. Although commonly self-limiting, a fraction of patients develop severely debilitating crusted scabies. The immune mechanisms underlying the development of crusted scabies are unclear, and undertaking longitudinal infection studies in humans is difficult. We utilized a porcine model to compare cellular immune responses in peripheral blood and skin of pigs with different clinical manifestations of scabies (n = 12), and in uninfected controls (n = 6). Although clinical symptoms were not evident until at least 4 weeks post-infestation, the numbers of peripheral IFNγ-secreting CD4(+) T cells and γδ T cells increased in infected pigs from week 1 post-infestation. γδ T cells remained increased in the blood at week 15 post-infestation. At week 15, skin cell infiltrates from pigs with crusted scabies had significantly higher CD8(+) T cell, γδ T cell and IL-17(+) cell numbers than those with ordinary scabies. Peripheral IL-17 levels were not increased, suggesting that localized skin IL-17-secreting T cells may play a critical role in the pathogenesis of crusted scabies development. Given the potential of anti-IL-17 immunotherapy demonstrated for other inflammatory skin diseases, this study may provide a novel therapeutic avenue for patients with recurrent crusted scabies.


Asunto(s)
Interleucina-17/inmunología , Sarcoptes scabiei/fisiología , Escabiosis/inmunología , Escabiosis/patología , Linfocitos T/inmunología , Animales , Inmunidad Celular , Interleucina-17/sangre , Distribución Aleatoria , Escabiosis/sangre , Escabiosis/parasitología , Piel/inmunología , Piel/patología , Sus scrofa
17.
AME Case Rep ; 8: 30, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38711879

RESUMEN

Background: Crusted scabies is a rare form of parasitic infection provoked by a massive infestation of the ectoparasite Sarcoptes scabiei varietas hominis on human skin. It is an extremely contagious type of disease and can even lead to a social stigma. In European countries like Greece, many cases remain undiagnosed for long periods, causing extreme distress in the patient's everyday life and social environment. Case Description: Herein, we present a case of an 86-year-old woman with crusted scabies in Greece, who remained undiagnosed for 5 months. Massive hyperkeratotic plaques on the extremities, and face, palmoplantar keratoderma, and numerous small erythematous papules on the torso with extreme itch were the main clinical manifestations of the patient. Dermoscopy revealed the parasite. All necessary decontamination measures were taken by personnel. Treatment was administered and a complete cure of the disease was observed. Conclusions: In this case, the use of dermoscopy has attributed to precise crusted scabies diagnosis and acute pharmacological management of the patient. Early diagnosis of such diseases not only saves patients from lethal secondary infections, but also reduces the risk of a massive scabies outbreak. We also conducted a mini-review, analyzing all recent data concerning crusted scabies macroscopic, dermatoscopic, and histological images. All new information concerning the pathophysiological mechanism of crusted scabies manifestation, updated treatment options, and potential resistance to widely-used treatments are provided.

18.
Clin Case Rep ; 12(5): e8854, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38689688

RESUMEN

Crusted scabies is a severe form of scabies infestation caused by the ectoparasite Sarcoptes scabiei. Risk factors include immunosuppression, neuropathies, and psychiatric disorders. Its management poses important challenges due to its contagius nature. Here we present a case or Acute Generalized Exanthematous Pustulosis secondary to Ivermectin therapy in a patient with crusted scabies.

19.
Skin Appendage Disord ; 10(1): 60-68, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38318430

RESUMEN

Introduction: Nail unit infestation by scabies mites (ungual scabies) is uncommon. It usually presents with distal subungual lesions, leading to recurrent and persistent disease by acting as a reservoir of infection. Periungual involvement in scabies with nail loss is rare and may lead to severe nail damage. Case Presentation: We report a 14-year-old boy on chemotherapy for acute lymphocytic leukemia (ALL) who presented with extensive scaling and crusted plaques of scabies. Nail unit revealed periungual crusted plaques with paronychia and onychomadesis involving five digits. It was associated with partial to complete nail loss. Dermoscopy of periungual crusted plaques showed greyish-white scales with brown dots and globules. A sinuous burrow with a brown-triangular structure was visualized in the web space. KOH mount from skin scrapings showed the scabies mites. Treatment of scabies led to a marked improvement. Conclusion: Though ungual scabies is generally a benign disease, proximal periungual involvement with damage to nail matrix is possible, leading to nail loss. We review manifestations of nail unit scabies reported in literature. Treatment options used and outcomes are also analyzed. The importance of nail-directed therapy in preventing relapses of scabies cannot be undermined.

20.
Int J Infect Dis ; 143: 107036, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38570134

RESUMEN

OBJECTIVES: Crusted scabies (CS, Norwegian scabies) is a severe form of scabies, characterized by hyper-infestation of Sarcoptes scabiei mites. CS is commonly associated with immunosuppression but is also reported in overtly immunocompetent individuals. We reviewed immunosuppressive risk factors and comorbidities associated with CS. METHODS: The National Library of Medicine (PubMed) database was reviewed for patient case reports of CS from January 1998 to July 2023. Two authors screened records for eligibility, extracted data, and one critically appraised the quality of the studies. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42023466126. RESULTS: A total of 436 records were identified, of which 204 were included for systematic review. From these, 683 CS patients were included. CS impacted both genders equally. Adults (21-59 years) were more commonly affected (45.5%) compared to children (0-20 years, 21%). Corticosteroid use was the most prevalent immunosuppressive risk factor identified (27.7% of all cases). About 10.2% of reports were associated with HIV/AIDS, and 8.5% with HTLV-1 infection. 10.5% of patients were overtly immunocompetent with no known risk factors. Overall, 41 (6.0%) died, many subsequent to secondary bacteremia. CONCLUSION: This study represents the first systematic review undertaken on immunosuppressive risk factors associated with CS. This provides insights into trends of immunosuppression and mechanisms of CS development.


Asunto(s)
Comorbilidad , Huésped Inmunocomprometido , Escabiosis , Escabiosis/epidemiología , Humanos , Factores de Riesgo , Femenino , Masculino , Adulto , Persona de Mediana Edad , Adulto Joven , Adolescente , Niño , Animales , Lactante , Sarcoptes scabiei , Infecciones por VIH/epidemiología , Infecciones por VIH/complicaciones , Preescolar , Infecciones por HTLV-I/epidemiología , Infecciones por HTLV-I/complicaciones , Terapia de Inmunosupresión , Recién Nacido
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA